Prevest Denpro P/E Ratio
Prevest Denpro (PREVEST) P/E ratio is 22.79 (Moderate), EPS (TTM) ₹15.13, current price ₹ on None — High - Growth expectations or overvalued. For live price, revenue and the complete fundamental profile, see PREVEST share price.
Current P/E Ratio
22.79
Moderate Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
22.79
Current Price
₹
EPS (TTM)
₹15.13
Exchange
None
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
49.39
Sector Median
27.18
Sector Rank
#11 of 139
Sector Percentile
7.9%
Earnings Breakdown (TTM)
TTM EPS
₹16.50
Sept 2025
₹4.62
Mar 2025
₹4.28
PREVEST P/E Ratio — Valuation Signal & Historical Context
Prevest Denpro P/E 22.79 — signal: Overvalued. Analyse PREVEST shareholder distribution to track promoter, FII and institutional holdings.
- Trading at discount to sector average PE of 49.39
PREVEST vs Healthcare Peers — P/E Ratio Comparison
Prevest Denpro P/E 22.79 vs Healthcare average 49.39, median 27.18 — range 1.17–869.57.
Sector Average
49.39
Sector Median
27.18
Lowest P/E
1.17
Highest P/E
869.57
Companies
139
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.17 | ₹43 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.93 | ₹1,136 | Low |
| Amwill Health Care | AMWILL | 6.78 | ₹73 | Low |
| Zenith Drugs | ZENITHDRUG | 7.55 | ₹73 | Low |
| Unichem Laboratories | UNICHEMLAB | 7.99 | ₹2,364 | Low |
| Medicamen Organics | MEDIORG | 8.01 | ₹32 | Low |
| Galaxy Medicare | GML | 8.78 | ₹31 | Low |
| Brooks Laboratories | BROOKS | 9.86 | ₹211 | Low |
| Vasundhara Rasayans | VRL | 11.05 | ₹40 | Low |